RRosenblatt AApple · AAPL

Rosenblatt Raises Apple Price Target to $300

Jul 31, 2026· 1 min read· Reproduced verbatim
Rating
Hold
Price target
$300
Previous
Implied downside
-10%

Rosenblatt analyst Barton Crockett reiterated a Neutral rating and $300 price target on Apple (NASDAQ: AAPL).

“Apple’s F3Q26 earnings report post-close Thurs. was close to in line, excluding tariff refund benefits, with this year’s story of exceptional strength in iPhone continuing, as we approach the big test next year of comp-ing that growth.

But the growth outlook slows some due in part to supply chain constraints.

With Apple shares trading near past high P/Es, and iPhone in our view likely to slow substantially next year against tough comps — like past big iPhone cycles — we retain a NEUTRAL rating.

We move our price target up $24 to $300, by moving ahead a year, and assuming maintenance of a premium P/E near 31 versus F2027, elevated versus an EPS CAGR we see normalizing in the low double digits, and near past peaks.

While we are in a volatile environment of cost inflation, tariffs, and supply chain constraints, our estimates are only modestly changed.”

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Share

Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.